New Regimen Boosts DLBCL Treatment: BTK Inhibitors, Rituximab, Lenalidomide
In a significant leap in treating newly diagnosed diffuse large B-cell lymphoma (DLBCL), researchers have unveiled promising results from a ...
In a significant leap in treating newly diagnosed diffuse large B-cell lymphoma (DLBCL), researchers have unveiled promising results from a ...
